Metastatic castration-resistant prostate is an advanced form of the cancer that’s incurable. Learn about treatment options ...

Metastatic castration-resistant prostate cancer causes urinary symptoms, fatigue, pain, and more. This article covers the ...

Prostate health is something every man should be aware of yet few people want to discuss. An enlarged prostate – called benign prostatic hyperplasia (BPH) – can lead to the need for surgery, which ...

A new technology is offering hope to men with low to intermediate-risk prostate cancer by providing a less invasive treatment option. Dr. Chris Reising, a surge ...

The test uses urine analysis to check for several indicators of prostate cancer. It can be even be done at home.

If you have a lawn, you'll almost certainly have spurge weeds. Knowing about them can help you deal with them so they don't ruin your lawn.

Get Instant Summarized Text (Gist) TBX2 protein acts as a switch in prostate cancer, shifting signaling from the androgen receptor to the glucocorticoid receptor, leading to treatment resistance ...

As time goes by, the risk of prostate cancer among men is increasing. The World Health Organization (WHO) states that prostate cancer is the most common cancer in men after lung cancer. According to ...

But truly deleting your personal genetic information from the DNA testing company is easier said than done. This story was originally published in October 2024. In March 2025, 23andMe filed for ...

It’s a rite of passage that fills men of a certain age with dread: the digital exam for prostate cancer. But suffering prostate cancer is even worse — especially since the treatments come with the ...

The trial analyzed outcomes for 344 men diagnosed with prostate cancer who were due to undergo prostate removal and who had no prior issues with erectile dysfunction.

during prostate removal. The pioneering method includes an additional test to ensure that all of the cancerous cells are removed, so that preserving the nerves does not risk the surgery’s success. In ...